970 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Acquired by Thurston Springer Miller Herd & Titak Inc.

Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 970 shares of the company’s stock, valued at approximately $76,000.

Other large investors also recently bought and sold shares of the company. Capital Research Global Investors increased its holdings in GE HealthCare Technologies by 5.2% in the 1st quarter. Capital Research Global Investors now owns 53,991,923 shares of the company’s stock valued at $4,908,406,000 after purchasing an additional 2,647,204 shares in the last quarter. Vanguard Group Inc. increased its stake in GE HealthCare Technologies by 9.2% during the 1st quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock worth $4,410,893,000 after buying an additional 4,107,746 shares during the period. Hotchkis & Wiley Capital Management LLC lifted its holdings in GE HealthCare Technologies by 9.4% in the 4th quarter. Hotchkis & Wiley Capital Management LLC now owns 5,511,973 shares of the company’s stock worth $426,186,000 after buying an additional 471,910 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in GE HealthCare Technologies by 17.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,454,690 shares of the company’s stock valued at $267,121,000 after buying an additional 504,287 shares during the last quarter. Finally, Norges Bank acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at about $229,052,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. The Goldman Sachs Group began coverage on GE HealthCare Technologies in a research note on Thursday, May 30th. They set a “neutral” rating and a $87.00 price objective for the company. Stifel Nicolaus assumed coverage on shares of GE HealthCare Technologies in a report on Tuesday. They issued a “buy” rating and a $100.00 price target on the stock. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Bank of America lowered their price objective on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Finally, Mizuho decreased their price objective on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a report on Wednesday, May 1st. Five equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $94.58.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC traded up $0.19 during trading hours on Wednesday, hitting $81.74. The stock had a trading volume of 136,659 shares, compared to its average volume of 3,118,289. The stock’s fifty day simple moving average is $79.00 and its 200 day simple moving average is $82.61. The firm has a market capitalization of $37.31 billion, a price-to-earnings ratio of 23.85, a PEG ratio of 3.00 and a beta of 1.17. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.83 and a current ratio of 1.06. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The company had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. During the same period last year, the company earned $0.92 earnings per share. The company’s quarterly revenue was up .5% compared to the same quarter last year. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be paid a dividend of $0.03 per share. The ex-dividend date is Friday, July 19th. This represents a $0.12 annualized dividend and a yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Jan Makela sold 20,227 shares of GE HealthCare Technologies stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $81.57, for a total value of $1,649,916.39. Following the transaction, the chief executive officer now owns 63,348 shares in the company, valued at $5,167,296.36. The transaction was disclosed in a document filed with the SEC, which is available at this link. In related news, CEO Jan Makela sold 20,227 shares of GE HealthCare Technologies stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $81.57, for a total value of $1,649,916.39. Following the transaction, the chief executive officer now owns 63,348 shares of the company’s stock, valued at approximately $5,167,296.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CTO Taha Kass-Hout sold 3,300 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total transaction of $259,710.00. Following the completion of the transaction, the chief technology officer now owns 67,300 shares of the company’s stock, valued at $5,296,510. The disclosure for this sale can be found here. Insiders have sold a total of 90,482 shares of company stock valued at $7,369,137 over the last three months. Company insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.